GHO Capital and Ampersand Acquire Avid Bioservices
US-based biologics CDMO Avid Bioservices will be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion. The three companies have signed the corresponding agreement.
Nick Green, President and CEO of Avid Bioservices, said: "Since its inception, Avid Bioservices' business has evolved to meet the broad development and manufacturing needs of our customers. After years of investment and expansion, now is the right time to move forward as a private company with new owners who will support our next phase of growth. In evaluating this transaction, our Board considered a range of alternatives and determined that this transaction provides significant, immediate and certain cash value to our shareholders. Partnering with GHO Capital and Ampersand Capital Partners allows us to leverage their extensive knowledge base, networks and capital to build on our strong foundation and position us for future growth for our customers."
GHO Managing Partners Alan MacKay and Mike Mortimer commented: "As experienced CDMO industry investors, GHO has deep expertise and experience to support the Avid management team as we move forward."
Ampersand Partner David Anderson said: "Avid has long been a trusted provider of biopharmaceutical development and manufacturing services, and we have great respect for its team’s expertise, broad range of customized services, and strong regulatory record. We look forward to leveraging our deep industry experience, focused strategy, and collaborative approach to drive growth.”
The transaction has been unanimously approved by Avid’s Board of Directors and is expected to close in the first quarter of 2025, subject to customary closing conditions.
2026-10-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Kumho Mitsui Chemicals to Further Expand MDI Production, Annual Capacity to Reach 710,000 Tons
-
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou
-
China’s Chemical “Spring Surge”: 68.8% of Products Rising—Real Recovery or Just a Pre-Festival Mirage?
-
SK Chemicals Partners with China’s Kelinle to Build Its Own Waste-Plastic Supply Network
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
Selling the Family Silver for a New Suit? Why Bohai Chemical’s Transformation Drama Got Canceled After Just Two Acts
-
“Changing the Captain at Sea”: Hempel’s CEO Departs to Run a Ferry Giant—This Isn’t a Resignation Notice, It’s an Industry Stress Map
-
Uzbekistan Bets $17 Billion on Chemical Industry Upgrade
-
US MDI Supply Squeeze Triggers Price Hikes
-
ADNOC Reroutes Naphtha via Oman to Bypass Hormuz Risk
Recommend Reading
-
Global Biologicals M&A Storm: How 2025 Redrew the Agricultural Innovation Map
-
Australia Launches Anti-Circumvention Trade Probe into China’s 2,4-D Supply Chain
-
He Spent 40 Years at Nestlé—Then Was “Cleared Out” Days After Becoming CEO: This Isn’t a Scandal, It’s Capital’s Coldest Face
-
Three Major Indian Chemical Investments Target China's PC Exports
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
Business Society September 17, 2026 BDO Trend Analysis: Strong Consolidation
-
Raw Material Strength and Weak Demand Lead to PC Fluctuations in January in China
-
January Ethylene Glycol Stabilizes and Stops Falling, Enters Range-bound Oscillation
-
Business Society’s Ethanol Trend Analysis for September 17, 2026: Volatile Consolidation
-
Costs Rise, January PP Follows Upstream Prices
- Hot Searches
- boric acid supplier
- n-acetyl sulfonyl chloride
- dicalcium phosphate price
- raw testosterone powder
- retatrutide glp-3 for sale
- where can you buy sulphur hexafluoride
- pfizer nurtec
- ammonia nitrate prill
- sodium carbonate material safety data sheet
- na-931 buy online
- cost of calcitonin nasal spray
- reda peptide buy